Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Autologous Peripheral Blood Stem Cell Transplantation for POEMS Syndrome

Chikako Ohwada, MD, PhD, Chiaki Nakaseko, Yusuke Takeda, Daijiro Abe, Masahiro Takeuchi, Emiko Sakaida, Shinichi Masuda, Naomi Shimizu, Ryuko Cho, Miki Nishimura, Kazuaki Kanai, Sonoko Misawa, Satoshi Kuwabara

Blood (2008) 112 (11): 4434.

https://doi.org/10.1182/blood.V112.11.4434.4434

Published: 2008

Journal Articles

Long-Term Follow-up of the Randomized JALSG AML 201 Study Comparing High Dose Ara-C Therapy with Conventional Consolidation Therapy in Adult Acute Myeloid Leukemia (AML)

Blood (2008) 112 (11): 135.

https://doi.org/10.1182/blood.V112.11.135.135

Published: 2008

Journal Articles

Updated Results of JALSG AML201 Study Comparing Intensified Daunorubicin with Idarubicin in Patients with De Novo Acute Myeloid Leukemia: Effect of Hematopoietic Stem Cell Transplantation.

Blood (2008) 112 (11): 2171.

https://doi.org/10.1182/blood.V112.11.2171.2171

Published: 2008

Journal Articles

Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndrome

Daijiro Abe, Chiaki Nakaseko, Masahiro Takeuchi, Hiroaki Tanaka, Chikako Ohwada, Emiko Sakaida, Yusuke Takeda, Kayo Oda, Shinichi Ozawa, Naomi Shimizu, Shinichi Masuda, Ryuko Cho, Miki Nishimura, Sonoko Misawa, Satoshi Kuwabara, Yasushi Saito

Blood (2008) 112 (3): 836–839.

https://doi.org/10.1182/blood-2007-12-126979

Published: 2008

Journal Articles

Restricted Oligo-Clonal Usage of Monoclonal Immunoglobulin λ Light Chain Germline in POEMS Syndrome.

Chiaki Nakaseko, MD, PhD, Daijiro Abe, MD, Masahiro Takeuchi, MD, Yusuke Takeda, MD, Hiroaki Tanaka, MD, Kayo Oda, MD, Chikako Ohwada, MD, PhD, Shinichi Ozawa, MD, PhD, Emiko Sakaida, MD, PhD, Naomi Shimizu, MD, PhD, Shinichi Masuda, MD, PhD, Ryuko Cho, MD, PhD, Miki Nishimura, MD, PhD, Yasushi Saito, MD, PhD, Sonoko Misawa, MD, PhD, Satoshi Kuwabara, MD, PhD

Blood (2007) 110 (11): 2483.

https://doi.org/10.1182/blood.V110.11.2483.2483

Published: 2007

Journal Articles

Identification of a Novel TEL-Lyn Fusion Gene in Chronic Eosinophilic Leukemia with ins (12;8)(p13;q11q21): Effect on Myeloproliferative Transformation and Induction of Myelofibrosis.

Hiroaki Tanaka, MD, Masahiro Takeuchi, MD, Yusuke Takeda, MD, Kayo Oda, MD, Daijiro Abe, MD, Chikako Ohwada, MD, PhD, Shinichi Ozawa, MD, PhD, Emiko Sakaida, MD, PhD, Naomi Shimizu, MD, PhD, Ryuko Cho, MD, PhD, Miki Nishimura, MD, PhD, Yasushi Saito, MD, PhD, Satoru Miyagi, PhD, Atsushi Iwama, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2007) 110 (11): 60.

https://doi.org/10.1182/blood.V110.11.60.60

Published: 2007

Journal Articles

Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.

Kazunori Ohnishi, Miki Nishimura, Jin Takeuchi, Shin Fujisawa, Tadashi Nagai, Koichi Miyamura, Yukihiko Kimura, Fumiharu Yagasaki, Hideki Akiyama, Noriko Usui, Shigeki Ohtake, on behalf of JALSG

Blood (2007) 110 (11): 1044.

https://doi.org/10.1182/blood.V110.11.1044.1044

Published: 2007

Journal Articles

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Blood (2007) 110 (1): 59–66.

https://doi.org/10.1182/blood-2006-08-043992

Published: 2007

Includes: Supplemental data

Journal Articles

Incidence, Risk Factors and Outcomes of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation.

Chiaki Nakaseko, MD, Shinnichi Ozawa, MD, Miki Nishimura, MD, Miwa Sakai, MD, Kumi Ohshima, MD, Yoshinobu Kanda, MD, Satoshi Takahashi, MD, Takayuki Shimizu, MD, Shinichiro Okamoto, MD, Akira Yokota, MD, Fumiaki Yoshiba, MD, Katsumichi Fujimaki, MD, Heiwa Kanamori, MD, Rika Sakai, MD, Takafumi Matsushima, MD, Tohru Sakura, MD, Hisashi Sakamaki, MD

Blood (2006) 108 (11): 3365.

https://doi.org/10.1182/blood.V108.11.3365.3365

Published: 2006

Journal Articles

Randomized Clinical Trial of Induction Therapy Comparing Intensified Daunorubicin with Idarubicin in Patients with Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study).

Blood (2006) 108 (11): 2000.

https://doi.org/10.1182/blood.V108.11.2000.2000

Published: 2006

Journal Articles

Clonal Expansion of MLL-ELL Rearrangement without Relapse of Leukemia after Treatment of MLL-ELL Positive AML; with a Rare Breakpoint in MLL Gene.

Masahiro Takeuchi, Shinichi Ozawa, Chikako Ohwada, Shinichi Masuda, Ryuko Cho, Chiaki Nakaseko, Miki Nishimura, Satoshi Miyagi, Atsushi Iwama, Motoharu Fukazawa, Yasushi Saito

Blood (2006) 108 (11): 4453.

https://doi.org/10.1182/blood.V108.11.4453.4453

Published: 2006

Journal Articles

Detection of BCR-ABL Transcript by Quantitative Real-Time PCR and Amp-CML (Transcript Mediated Amplification) during Imatinib Therapy for Chronic Myeloid Leukemia.

Koichi Miyamura, Fumiharu Yagasaki, Taiichi Kyo, Kazunori Ohnishi, Tomoki Naoe, Hitoshi Takeuchi, Miki Nishimura, Shin Fujiwara, Tetsuzo Tauchi, Ryuzo Ohno

Blood (2006) 108 (11): 4791.

https://doi.org/10.1182/blood.V108.11.4791.4791

Published: 2006

Journal Articles

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison between High Dose Ara-C Therapy and Conventional Consolidation Therapy (JALSG AML 201 Study).

Blood (2006) 108 (11): 2005.

https://doi.org/10.1182/blood.V108.11.2005.2005

Published: 2006

Journal Articles

A Randomized Study with or without Intensified Maintenance Chemotherapy in Patients with Acute Promyelocytic Leukemia Who Had Become Negative for PML-RARα Transcript after Consolidation Therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 Study.

Norio Asou, MD, Yuji Kishimoto, MD, Hitoshi Kiyoi, MD, Masaya Okada, MD, Yasukazu Kawai, MD, Motohiro Tsuzuki, MD, Kentaro Horikawa, MD, Mitsuhiro Matsuda, MD, Katsuji Shinagawa, MD, Tohru Kobayashi, MD, Shigeki Ohtake, MD, Miki Nishimura, MD, Masatomo Takahashi, MD, Fumiharu Yagasaki, MD, Akihiro Takeshita, MD, Yukihiko Kimura, MD, Masako Iwanaga, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2006) 108 (11): 2009.

https://doi.org/10.1182/blood.V108.11.2009.2009

Published: 2006

Journal Articles

Risk Factors and Outcome of Chronic GVHD: Analysis of 5,660 Patients Undergoing Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.

Chiaki Nakaseko, Miki Nishimura, Shinnichi Ozawa, Ryuko Cho, Chikako Ohwada, Atsuo Maruta, Hisashi Sakamaki, Hiroshi Sao, Shin-ichiro Mori, Shinichiro Okamoto, Koichi Miyamura, Shunichi Kato, Tadakazu Kawase, Yasuo Morishima, Yoshihisa Kodera

Blood (2005) 106 (11): 139.

https://doi.org/10.1182/blood.V106.11.139.139

Published: 2005

Journal Articles

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

Blood (2005) 106 (8): 2854–2861.

https://doi.org/10.1182/blood-2005-04-1733

Published: 2005

Includes: Supplemental data

Journal Articles

Zoledronate Can Overcome Drug Resistance in a Dexamethasone Resistant Myeloma Cell Line.

Masayuki Koizumi, MD, Chiaki Nakaseko, PhD, Chikako Ohwada, MD, Ryuko Cho, PhD, Miki Nishimura, PhD, Yasushi Saito, PhD

Blood (2004) 104 (11): 4894.

https://doi.org/10.1182/blood.V104.11.4894.4894

Published: 2004

Journal Articles

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

Kazutaka Ozeki, Hitoshi Kiyoi, Yuka Hirose, Masanori Iwai, Manabu Ninomiya, Yoshihisa Kodera, Shuichi Miyawaki, Kazutaka Kuriyama, Chihiro Shimazaki, Hideki Akiyama, Miki Nishimura, Toshiko Motoji, Katsuji Shinagawa, Akihiro Takeshita, Ryuzo Ueda, Ryuzo Ohno, Nobuhiko Emi, Tomoki Naoe

Blood (2004) 103 (5): 1901–1908.

https://doi.org/10.1182/blood-2003-06-1845

Published: 2004

Journal Articles

Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect

Emiko Sakaida, Chiaki Nakaseko, Akane Harima, Akira Yokota, Ryuko Cho, Yasushi Saito, Miki Nishimura

Blood (2003) 102 (12): 4236–4242.

https://doi.org/10.1182/blood-2002-10-3289

Published: 2003

NARROW

Autologous Peripheral Blood Stem Cell Transplantation for POEMS Syndrome

Long-Term Follow-up of the Randomized JALSG AML 201 Study Comparing High Dose Ara-C Therapy with Conventional Consolidation Therapy in Adult Acute Myeloid Leukemia (AML)

Updated Results of JALSG AML201 Study Comparing Intensified Daunorubicin with Idarubicin in Patients with De Novo Acute Myeloid Leukemia: Effect of Hematopoietic Stem Cell Transplantation.

Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndrome

Restricted Oligo-Clonal Usage of Monoclonal Immunoglobulin λ Light Chain Germline in POEMS Syndrome.

Identification of a Novel TEL-Lyn Fusion Gene in Chronic Eosinophilic Leukemia with ins (12;8)(p13;q11q21): Effect on Myeloproliferative Transformation and Induction of Myelofibrosis.

Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Incidence, Risk Factors and Outcomes of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation.

Randomized Clinical Trial of Induction Therapy Comparing Intensified Daunorubicin with Idarubicin in Patients with Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study).

Clonal Expansion of MLL-ELL Rearrangement without Relapse of Leukemia after Treatment of MLL-ELL Positive AML; with a Rare Breakpoint in MLL Gene.

Detection of BCR-ABL Transcript by Quantitative Real-Time PCR and Amp-CML (Transcript Mediated Amplification) during Imatinib Therapy for Chronic Myeloid Leukemia.

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison between High Dose Ara-C Therapy and Conventional Consolidation Therapy (JALSG AML 201 Study).

A Randomized Study with or without Intensified Maintenance Chemotherapy in Patients with Acute Promyelocytic Leukemia Who Had Become Negative for PML-RARα Transcript after Consolidation Therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 Study.

Clinical Characteristics and Prognostic Implications of NPM1 Mutations in Acute Myeloid Leukemia.

Risk Factors and Outcome of Chronic GVHD: Analysis of 5,660 Patients Undergoing Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

Zoledronate Can Overcome Drug Resistance in a Dexamethasone Resistant Myeloma Cell Line.

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only